Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complicationsResearch in context

Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complicationsResearch in context

Summary: Background: Herpes zoster (HZ) vaccines should provide durable protection against HZ and HZ-related complications. We report the final analysis of a long-term follow-up (LTFU) study (ZOE-LTFU) including 11 years of follow-up after primary vaccination with recombinant zoster vaccine (RZV)....

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Strezova, Javier Díez Domingo, Anthony L. Cunningham, Takashi Eto, Charles Andrews, Clovis Arns, Eun-Ju Choo, David Shu Cheong Hui, Giancarlo Icardi, Shelly A. McNeil, Airi Põder, Pavel Kosina, Lars Rombo, Tino F. Schwarz, Juan Carlos Tinoco, Chong-Jen Yu, Jing Wang, Jyoti Soni, Manyee Tsang, Rafael Leon, Agnes Mwakingwe-Omari
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:EClinicalMedicine
Subjects:
Recombinant zoster vaccine
Herpes zoster
Post-herpetic neuralgia
Long-term follow-up
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537025001737
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2589537025001737

Similar Items